Zynex Inc 's ability to collect accounts receivable sequentially worsen to 8.82, indicating more challenging environment then in the second quarter 2025, but still, it is a far cry from any concerns. Zynex Inc 's Accounts Receivable average collection period in the Sep 30 2025 quarter, has increased to 41 days, from 40 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 147 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 503 to 1480.

What is Receivable Turnover Ratio?
What is Zynex Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ZYXI Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-69.04 %	-56.15 %	-44.76 %	-32.85 %	-35.04 %
Y / Y Revenue Change	-73.26 %	-55.32 %	-42.88 %	-2.66 %	0.1 %
Receivable Turnover Ratio (TTM)	8.82	9.05	8.92	8.68	7.95
ZYXI's Total Ranking	# 1480	# 503	# 599	# 1085	#
Accounts Receivable average collection period days	41	40	41	42	46
Seq. Receivable Change	-35.28 %	-26.39 %	-22.02 %	-16.65 %	-8.35 %
Seq. Revenue Change	-40.06 %	-16.13 %	-42.25 %	-7.89 %	0.17 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 45
Healthcare Sector	# 148
Overall Market	# 1480

Receivable Turnover Ratio Statistics
High	Average	Low
11.95	6.36	1.78
(Jun 30 2019)		(Jun 30 2014)

ZYXI Company Profile • Back to ZYXI Efficiency Comparisons • Compare ZYXI Receivables Turnover Ratio to its Competitors

Financial Statements
Zynex Inc 's Accounts Receivable	$ 7 Millions	Visit ZYXI's Balance sheet
Zynex Inc 's Sales TTM	$ 108 Millions	Visit ZYXI's Income Statement
Sources of ZYXI's Revenues		Visit ZYXI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ZYXI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ZYXI's Growth Rates	ZYXI's Roa	ZYXI's Inventory Turnover Ratio	ZYXI's Dividend Comparisons
ZYXI's Profitability Ratios	ZYXI's Roi	ZYXI's Asset Turnover Ratio	ZYXI's Dividend Growth
ZYXI's Valuation Ratios	ZYXI's Roe	ZYXI's Financial Strength Ratios	ZYXI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Marpai Inc	38.88	$ 20.702 Millions	$ 0.533 Millions
Nature s Sunshine Products inc	38.67	$ 474.009 Millions	$ 12.258 Millions
National Vision Holdings Inc	38.15	$ 1,861.626 Millions	$ 48.800 Millions
X4 Pharmaceuticals Inc	37.60	$ 33.979 Millions	$ 0.904 Millions
Kyntra Bio Inc	37.51	$ 8.298 Millions	$ 0.221 Millions
Orchestra Biomed Holdings Inc	35.67	$ 2.818 Millions	$ 0.079 Millions
Lineage Cell Therapeutics Inc	35.06	$ 10.816 Millions	$ 0.309 Millions
Wave Life Sciences Ltd	33.51	$ 109.230 Millions	$ 3.260 Millions
Invo Fertility Inc	32.11	$ 6.944 Millions	$ 0.216 Millions
Metagenomi Therapeutics Inc	30.14	$ 30.913 Millions	$ 1.025 Millions
Vireo Growth Inc.	29.54	$ 189.242 Millions	$ 6.407 Millions
Longeveron Inc	29.33	$ 1.437 Millions	$ 0.049 Millions
U S Physical Therapy Inc	29.22	$ 758.711 Millions	$ 25.966 Millions
Innovative Eyewear Inc	28.24	$ 2.393 Millions	$ 0.085 Millions
Polomar Health Services, Inc.	27.46	$ 0.037 Millions	$ 0.001 Millions
Keros Therapeutics Inc	27.14	$ 266.962 Millions	$ 9.835 Millions
Lifemd Inc	26.96	$ 250.860 Millions	$ 9.306 Millions
Cv Sciences Inc	24.73	$ 11.758 Millions	$ 0.476 Millions
Immunocore Holdings Plc	24.10	$ 379.590 Millions	$ 15.752 Millions
Aquestive Therapeutics Inc	23.64	$ 43.397 Millions	$ 1.836 Millions
Innovage Holding Corp	23.27	$ 884.662 Millions	$ 38.013 Millions
Safe Pro Group Inc	23.20	$ 1.267 Millions	$ 0.055 Millions
Fonar Corporation	22.87	$ 105.434 Millions	$ 4.609 Millions
Electrocore Inc	22.58	$ 28.883 Millions	$ 1.279 Millions
Igc Pharma Inc	22.01	$ 1.106 Millions	$ 0.050 Millions
Orthofix Medical Inc	21.02	$ 818.516 Millions	$ 38.934 Millions
Neuroone Medical Technologies Corp	20.67	$ 9.098 Millions	$ 0.440 Millions
Bioxcel Therapeutics Inc	20.32	$ 0.752 Millions	$ 0.037 Millions
Sonida Senior Living Inc	19.17	$ 375.417 Millions	$ 19.582 Millions
Nutriband Inc	19.13	$ 2.278 Millions	$ 0.119 Millions

Date modified: 2026-09-08T15:11:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.